Greenwich LifeSciences, Inc.GLSINASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-7.27M
↓ 124% below average
Average (7y)
$-3.24M
Historical baseline
Range
High:$-114952.00
Low:$-7.27M
CAGR
+79.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-7.27M | -12.2% |
| 2023 | $-6.48M | -4.5% |
| 2022 | $-6.20M | -44.5% |
| 2021 | $-4.29M | -272.2% |
| 2020 | $-1.15M | -293.1% |
| 2019 | $-293267.00 | -155.1% |
| 2018 | $-114952.00 | +4.9% |
| 2017 | $-120847.00 | - |